TIRZEPATIDE : A THOROUGH REVIEW

The emerging class of GLP-1 receptor agonist and GIP combined medications, including tirzepatide, semaglutide, and the recently introduced retatrutide, provide promising advances in diabetes control. While all three work by impacting sugar concentrations, they distinguish in their unique mechanis